On Route 128, a History of Constant Innovation
The completion of Route 128 changed Massachusetts and its commercial real estate industry more fundamentally than anything before, or perhaps since. And its evolution continues today.
The completion of Route 128 changed Massachusetts and its commercial real estate industry more fundamentally than anything before, or perhaps since. And its evolution continues today.
A Bedford office building is in line for a lab conversion after the project received an $82.2 million financing package.
Under its new CEO Peter Gottlieb, Hobbs Brook Real Estate is diversifying the geography and asset mix of its real estate portfolio from its traditional office and lab stomping grounds along Route 128 to different asset classes and regions of the country.
After offering an incentive to lab developers by raising building heights, the town of Lexington is challenging them to deliver buildings equipped with some of the suburbs’ most energy-efficient building systems.
Burlington’s latest effort to build a new suburban Boston life science cluster is getting traction among developers and spurring new activity in office parks set to be repositioned with biotech at the forefront.
It is Greater Boston’s frontier of urban planning: How do you adapt dated, low-rise shops and office buildings for a brave, new, post-COVID world while creating a greener future with more housing?
Lexington is taking steps to make life science development more attractive amid rising competition from nearby suburbs and expanding clusters in Boston, Somerville and Watertown.
Shared office space provider Inc.ubate Coworking has begun accepting applications for membership at its newest location, the historic Patton Homstead in Hamilton.
More than a few of these newcomers will quickly get a reality check, with the suburban starter home of today likely to be an old, small and grossly overpriced fixer-upper that no one else is ready to go massively into debt to buy.
A California-based biotech company says it plans to build a 100,000-square-foot factory in Bedford to supply clinical trials of several drugs it is currently developing.